Bioverativ Inc. Waltham , MA 02154
This Financial analyst positionsupports the Medical Affairs organization of Sanofi-Genzyme, with a focus on accountingand forecasting for key activities as well as Consolidation and Reporting forthe Sanofi-Genzyme Medical Affairs perimeter.
The position reports to the Head ofFinance for Sanofi Genzyme Medical Affairs and is based in Cambridge, MA.
Primary responsibilities include accounting,reporting and global forecasting of costs related to Clinical Studies,Reporting and Global forecasting of headcount for Sanofi-Genzyme MedicalAffairs, System supports, Consolidation and Reporting of financial informationfor the perimeter. The scope of work will encompass the newly created RareBlood disorder Unit, and the integration of Bioverativ activities into the
Sanofi systems and processes.
Accounting, reporting andglobal forecasting of costs related to Clinical Studies
The most important activitiesfor the Medical Affairs perimeter relates to the management of phase IVclinical studies supporting the entire portfolio of Sanofi-Genzyme. (InvestigatorSponsored Studies and Company Sponsored Studies)
Costs for those clinicalstudies are centrally managed in a TM1-Cognos based application named CASA.
In close relation with the MedicalAffairs Financial Controllers in charge of the supported Therapeutic Areas, theposition is in charge of ensuring accuracy and completeness of the datareported in CASA and managing key processes related to the application:
Responsible forclinical-studies month-end closing accounting activities and reporting requirementsin compliance with Sanofi accounting standards and corporate reportingrequirements and timelines,
Global reforecasting of clinical studies: Consolidation and validation ofclinical study drivers and costs in relation with Medical Affairs financialcontrollers and relevant clinical support functions.
Headcount forecasting andreporting
In charger of monitoring thereporting and forecasting of headcount and open positions for the
Sanofi-Genzyme Medical Affairs perimeter at global level.
In connection with the Medical Affairs Finance Controllers, coordinate the process of headcount forecasting and reporting in TM1-BOOST as well as the monthly reporting of Actuals for US Based employees.
Perform Global consolidation and variance analysis including ex-US employees. Identify and investigate gaps with the support of the Medical Affairs Finance controllers
Be the point of contact with the Medical Affairs HR representative to ensure accuracy of data reported.
Maintain and report Headcount dashboards including analysis and comments (Power Point, Thinkcell)
System support, consolidation and reporting
Assist the Medical AffairsFinance team in the critical steps of Global reporting and Consolidation, incoordination with the FP&A finance team of Sanofi Genzyme for all majorfinance exercises (actuals variance analysis, Forecast, budget and long Randplanning)
Maintain consolidation and reporting tools for Clinical studies reporting.Perform monthly reconciliation with HFM at global level.
Using excel andinternal financial systems (Hyperion/Essbase, Qlikview) to develop basic and moreadvanced models to assist in financial analysis
Interpretingfinancial information from countries and regions
Supporting thedevelopment of power point presentation to enhance management reports
Provide technicaland analytical support for numerous projects and analyses to supportachievement of Sanofi Genzyme Medical Affairs financial goals and businessobjectives, including the roll-out of a new SAP platform in 2019 as well ascontribution to different work streams aiming at OPEX optimization andreporting solutions.
3+ years inbusiness finance experience, with emphasis on financial analysis, budgeting,forecasting and month end close
BS inAccounting/Finance required; CPA or MBA a plus
Strong knowledge ofSAP and TM1/Boost is critical
Excellent knowledgeof Excel (reporting automation) and power point required
Strong accountingskills; Internal Controls
Knowledge ofHyperion, Essbase preferred
Open minded andteam player. Ability to interact easily with other finance groups andfunctions.
Bioverativ, a Sanofi company, is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 as an independent company spun out of Biogen's hemophilia business, we build upon a strong heritage of scientific innovation and are committed to actively working with the rare blood disorders community. The company's mission is to create progress for patients where they need it most and its hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.comOpens a New Window. or follow @bioverativ on Twitter.
We are an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status, or any other protected characteristic. VEVRAA Federal Contractor
We Request Priority Protected Veteran and Disabled Referrals for all our locations.
Bioverativ is an E-Verify Employer in the United States.